Abstract
Abstract A simple and stability indicating HPLC procedure is described for the simultaneous determination of hydrochlorothiazide and propranolol hydrochloride in tablet formulations. Potential degradation products of both drugs and synthesis impurities of hydrochlorothiazide were separated, making the determination stability indicating for both drugs and selective for hydrochlorothiazide. All compounds were chromatographed on a cyanopropylsilane column, eluted with a 15:85 mixture of acetonitrile: 0.05 M ammonium phosphate (pH 3.0) and detected at 290 m. Excellent interlaboratory precision and recovery data were obtained. Linearity studies were carried out using peak area measurements. Detector response to the concentration of each drug was confirmed. The method was applied to dosage forms containing 25 mg of hydrochlorothiazide and 40 or 80 mg of propranolol hydrochloride.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
